Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1698712

	registered interest
	date	20/03/2024
	answering body	Ministry of Justice
	answering dept id	54
	answering dept short name	Justice
	answering dept sort name	Justice
	hansard heading	Prison and Probation Service: Labour Turnover
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Justice, what steps he has taken to help increase the retention rate of staff in HM Prison and Probation Service.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	902217
	answer	answer is ministerial correction date of answer 27/03/2024 answer text <p>Safe, decent, rehabilitative prisons require excellent and experienced staff, as does supervising offenders in the community to keep the public safe.</p><p>We want them to stay in the Prison Service and to support retention, we have:</p><ul><li><p>Accepted every penny of the Prisons Service PRB pay recommendations for 2023/24.</p></li><li><p>Injected extra funding of more than £155 million a year since 2021 to support Probation staff to deliver more robust supervision.</p></li><li><p>Rolled out BWV to every officer, to help protect staff by defusing volatile situations.</p></li><li><p>Introduced a New Colleague Mentor scheme to help new recruits feel supported in their early weeks and months.</p></li></ul><p>Retention for prison officers is improving, with the staff resignation rate dropping from around 10.7% to around 8.3% over the last year to December 2023.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 27/03/2024 13:05:24 answering member 4362 label Biography information for Edward Argar
	tabling member	4124 label Biography information for Chi Onwurah

1483633

	registered interest
	date	27/06/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Professions: Racial Discrimination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the recommendation in the British Medical Association’s report entitled, Delivering Racial Equality in Medicine, what steps his Department is taking to help improve the complaints procedure for incidents of workplace racism in medical settings.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	25851
	answer	answer is ministerial correction date of answer 04/07/2022 answer text <p>Formal complaints procedures are conducted at individual National Health Service trust and provider level. Through the NHS People Plan, NHS England and NHS Improvement have launched a training programme for Freedom to Speak Up Guardians to improve understanding of inequality experienced by ethnic minority staff and to seek their views.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 26763 question first answered 04/07/2022 14:25:19 answering member 4362 label Biography information for Edward Argar
	tabling member	4124 label Biography information for Chi Onwurah

1484170

	registered interest
	date	28/06/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Racial Discrimination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to improve the complaints procedure for incidents of workplace racism in medical settings, as recommended in the British Medical Association’s report entitled Delivering racial equality in medicine, published in June 2022.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	26763
	answer	answer is ministerial correction date of answer 04/07/2022 answer text <p>Formal complaints procedures are conducted at individual National Health Service trust and provider level. Through the NHS People Plan, NHS England and NHS Improvement have launched a training programme for Freedom to Speak Up Guardians to improve understanding of inequality experienced by ethnic minority staff and to seek their views.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 25851 question first answered 04/07/2022 14:25:19 answering member 4362 label Biography information for Edward Argar
	tabling member	4124 label Biography information for Chi Onwurah

1483631

	registered interest
	date	27/06/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Professions: Racial Discrimination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the British Medical Association’s report entitled, Delivering racial equality in medicine, what steps he is taking to (a) protect and support medical professionals from racist abuse and (b) help ensure Black and Ethnic Minority groups are not dissuaded from pursuing medical careers.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	25850
	answer	answer is ministerial correction date of answer 30/06/2022 answer text <p>The National Health Service Civility and Respect programme aims to tackle discrimination, bullying and harassment in the NHS and to create positive workplace cultures.</p><p>The NHS is improving recruitment processes and career opportunities for all staff, including medical professionals, from ethnic minority backgrounds. The Medical Workforce Racial Equality Standard report in 2020 showed that the number of black and minority ethnic doctors increased by 21.1% compared to 2017. We have accepted the recommendations from the ‘Leadership for a collaborative and inclusive future’ review into health and social care leadership in full. The recommendations include embedding inclusive leadership practice as the responsibility of all and promoting equal opportunity and fairness standards to tackle discrimination.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 30/06/2022 12:43:12 answering member 4362 label Biography information for Edward Argar
	tabling member	4124 label Biography information for Chi Onwurah

1468907

	registered interest
	date	09/06/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Advanced Therapy Medicinal Products
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether he has had discussions with the Chancellor of the Exchequer on the suitability of the current 3.5 percent discount rate applied for assessing cost effectiveness of Advanced Therapy Medicinal Products (ATMP); and what assessment he has made of the potential merits of lowering this rate to better assess the long-term value and transformative effect of ATMPs.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	15257
	answer	answer is ministerial correction date of answer 15/06/2022 answer text <p>The National Institute for Health and Care Excellence (NICE) is an independent body responsible for the methods and processes used in the development of its guidance and recommendations. NICE recently concluded a comprehensive review of its methods and processes for health technology evaluation, including consideration of the discount rate and published its updated manual on 31 January. Officials from the Department of Health and Social Care and HM Treasury were engaged throughout the review.</p><p>Following a public consultation, NICE concluded that while there was some evidence to support a change to the reference case discount rate, it was appropriate to maintain the existing reference case discount rate of 3.5% due to wider policy and fiscal implications. NICE has retained the flexibility for its committees to apply a lower non-reference case discount rate of 1.5% in exceptional circumstances. This flexibility has previously been applied by NICE when evaluating advanced therapeutic medicinal products, such as its positive appraisal of the gene therapy Zolgensma for the treatment of spinal muscular atrophy.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 15/06/2022 09:57:06 answering member 4362 label Biography information for Edward Argar previous answer version 6254 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
	tabling member	4124 label Biography information for Chi Onwurah

1467849

	registered interest
	date	06/06/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Drugs: Licensing
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that new, innovative medicines are recommended by NICE as quickly as is possible; and what assessment he has made of the difference between the average wait time for access to new licensed medicines between NHS patients and patients in other OECD nations.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	13120
	answer	answer is ministerial correction date of answer 10/06/2022 answer text <p>The National Institute for Health and Care Excellence (NICE) aims to issue draft recommendations on new medicines close to the point of licensing, with final guidance within 90 days of licensing wherever possible. In 2021/22, NICE issued guidance within 90 days of licensing for 100% of new active substances where timelines were within NICE’s control. Topics outside of this timeframe were affected by external factors, such as where the pharmaceutical company requests a delay to NICE’s evaluation.</p><p>In 2022/23, NICE aims to increase the flexibility and capacity of its technology appraisal programme through a more proportionate approach to assessments. From April 2023, NICE aims to expand its capacity for technology appraisals by 20% to respond to increasing numbers of new medicines.</p><p>No specific assessment of the differences in average waiting times has been made. As countries operate different health systems, direct comparisons of patient access to medicines can be challenging. The EFPIA Patients W.A.I.T. Indicator 2021 Survey compares time to availability of new medicines across different European countries and is available at the following link:</p><p><a href="https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fefpia.eu%2Fmedia%2F636821%2Fefpia-patients-wait-indicator-final.pdf&amp;data=05%7C01%7CMD.Support%40dhsc.gov.uk%7C8ecb347eca8042c1b3bf08da4887894b%7C61278c3091a84c318c1fef4de8973a1c%7C1%7C0%7C637902044194848384%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=7K1WBv0pJ%2Ftp%2BvNud7cZwpakcprDuBl732PHx%2BvYN%2BA%3D&amp;reserved=0" target="_blank">https://efpia.eu/media/636821/efpia-patients-wait-indicator-final.pdf</a></p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 10/06/2022 08:32:27 answering member 4362 label Biography information for Edward Argar previous answer version 5359 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
	tabling member	4124 label Biography information for Chi Onwurah

1454069

	registered interest
	date	24/03/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health: Data Protection
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 December 2021 to Question 92932, and with reference to page 11 of the Life Sciences Vision, what plans his Department has to simplify governance and oversight of NHS health data to drive research and innovation; and how the Medical Technology Directorate will contribute to that.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	146619
	answer	answer is ministerial correction date of answer 26/04/2022 answer text <p>The Medical Technologies (MedTech) Directorate aligns with the Life Sciences Vision to supports the simplification of governance and oversight processes. The Directorate’s recently established data and analysis team will work with health and social care partners to strengthen the collection and use of evidence, improve national data standards and promote better integration of datasets in the MedTech Sector. More detail on the improvement of data governance will be published in the MedTech Strategy in summer 2022.</p><p>In addition, the newly created NHS Transformation Directorate is leading on data collection and management needs to fulfil the Life Sciences Vision. The MedTech Directorate will work with the NHS Transformation Directorate to support its aim of integrating National Health Service health and genomic datasets in the United Kingdom, to encourage innovation and clinical trials with diverse representation.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 26/04/2022 10:40:01 answering member 4362 label Biography information for Edward Argar
	tabling member	4124 label Biography information for Chi Onwurah

1454071

	registered interest
	date	24/03/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Technologies Directorate: Life Sciences
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 December 2021 to Question 92932, and with reference to page 10 of the Life Sciences Vision, what role the Medical Technologies Directorate will have in maintaining and growing investment in research into Life Sciences.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	146621
	answer	answer is ministerial correction date of answer 26/04/2022 answer text <p>The Medical Technologies (MedTech) Directorate supports the growth of investment in life sciences. Following the 2021 Spending Review, the Government has confirmed specific funds will be provided to directly support the delivery of the Life Sciences Vision.</p><p>The MedTech Directorate supports research with its stakeholders including regulators, the National Health Service, the Office for Life Sciences, the Health Research Authority and the National Institute for Health and Care Research, to promote evaluation and enhance patient outcomes. The MedTech Strategy intends to create an environment which attracts and supports investment and the Directorate will work with other Government departments to promote increased expenditure.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 26/04/2022 10:33:09 answering member 4362 label Biography information for Edward Argar
	tabling member	4124 label Biography information for Chi Onwurah

1458434

	registered interest
	date	19/04/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Professions: Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle the shortage of specialist cancer staff in the NHS workforce.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	155729
	answer	answer is ministerial correction date of answer 25/04/2022 answer text <p>We are investing an additional £50 million in 2022/23 to further expand the cancer and diagnostics workforce. Between 2016 and 2021, the annual growth rate of the overall cancer workforce has remained between 3 to 4%. The forthcoming 10 Year Cancer Plan will also ensure we have the right workforce in place.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 25/04/2022 12:29:24 answering member 4362 label Biography information for Edward Argar
	tabling member	4124 label Biography information for Chi Onwurah

1454070

	registered interest
	date	24/03/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Technologies Directorate: Life Sciences
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 December 2021 to Question 92932, and with reference to page 10 of the Life Sciences Vision, what assessment his Department has made of how the Medical Technologies Directorate can contribute to positioning the NHS as an Innovation Partner.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	146620
	answer	answer is ministerial correction date of answer 31/03/2022 answer text <p>The Medical Technologies Directorate is developing its strategy to be published in summer 2022, which will support the Life Sciences Vision. The Directorate has undertaken engagement with industry partners to identify the key priorities for the MedTech Strategy. This will include supporting an innovative and dynamic MedTech market to ensure that new products reach the National Health Service quickly through streamlined pathways. The forthcoming strategy will provide further details on this priority.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 31/03/2022 10:36:34 answering member 4362 label Biography information for Edward Argar
	tabling member	4124 label Biography information for Chi Onwurah